Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
156 | Anti-Obesity Drug Discovery and Development | book series | 0.133 Q4 | 1 | 0 | 7 | 0 | 0 | 1 | 0.00 | 0.00 | |
155 | Drug Discovery Today: Disease Models | journal | 0.665 Q2 | 33 | 0 | 23 | 0 | 64 | 20 | 0.00 | 0.00 | |
154 | Drug Discovery Today: Technologies | journal | 1.241 Q1 | 62 | 0 | 53 | 0 | 295 | 48 | 3.50 | 0.00 | |
153 | European Pharmaceutical Law Review | journal | 0.162 Q4 | 4 | 0 | 71 | 0 | 19 | 42 | 0.20 | 0.00 | |
152 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.111 Q4 | 1 | 0 | 12 | 0 | 1 | 3 | 0.00 | 0.00 | |
151 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.104 Q4 | 2 | 0 | 20 | 0 | 1 | 9 | 0.00 | 0.00 | |
150 | Journal of Experimental Therapeutics and Oncology | journal | 0.108 Q4 | 40 | 0 | 5 | 0 | 0 | 4 | 0.00 | 0.00 | |
149 | Pharmaceutical Care and Research | journal | 0.106 Q4 | 9 | 0 | 162 | 0 | 13 | 154 | 0.11 | 0.00 | |
148 | Antiviral Chemistry and Chemotherapy | journal | 0.369 Q3 | 59 | 2 | 29 | 41 | 62 | 28 | 0.87 | 20.50 | |
147 | Frontiers in Anti-infective Drug Discovery | book series | 0.209 Q4 | 3 | 1 | 7 | 124 | 3 | 1 | 0.17 | 124.00 | |
146 | Revista Cubana de Plantas Medicinales | journal | 0.105 Q4 | 16 | 7 | 71 | 159 | 5 | 62 | 0.04 | 22.71 | |
145 | Expert Review of Precision Medicine and Drug Development | journal | 0.257 Q4 | 16 | 3 | 102 | 251 | 92 | 79 | 0.90 | 83.67 | |
144 | VacciMonitor | journal | 0.133 Q4 | 5 | 14 | 59 | 264 | 15 | 51 | 0.15 | 18.86 | |
143 | Open Medicinal Chemistry Journal | journal | 0.289 Q4 | 23 | 9 | 22 | 476 | 47 | 19 | 2.80 | 52.89 | |
142 | International Journal of Computational Biology and Drug Design | journal | 0.120 Q4 | 16 | 14 | 80 | 527 | 27 | 79 | 0.50 | 37.64 | |
141 | Protein and Cell | journal | 4.412 Q1 | 94 | 83 | 257 | 551 | 2693 | 152 | 12.12 | 6.64 | |
140 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | |
139 | Recent Advances in Anti-Infective Drug Discovery | journal | 0.203 Q4 | 38 | 18 | 53 | 861 | 58 | 50 | 1.07 | 47.83 | |
138 | Chemotherapy | journal | 0.663 Q2 | 61 | 30 | 97 | 866 | 219 | 92 | 1.84 | 28.87 | |
137 | PPAR Research | journal | 0.698 Q2 | 59 | 15 | 69 | 877 | 199 | 69 | 3.25 | 58.47 | |
136 | Korean Journal of Pharmacognosy | journal | 0.140 Q4 | 18 | 32 | 102 | 880 | 33 | 101 | 0.35 | 27.50 | |
135 | Recent advances in inflammation & allergy drug discovery | journal | 0.443 Q3 | 37 | 19 | 42 | 1111 | 84 | 35 | 0.86 | 58.47 | |
134 | Trends in Phytochemical Research | journal | 0.290 Q3 | 8 | 18 | 73 | 1149 | 109 | 67 | 1.82 | 63.83 | |
133 | Pharmaceutical patent analyst | journal | 0.351 Q3 | 20 | 26 | 62 | 1235 | 71 | 50 | 1.18 | 47.50 | |
132 | Current Enzyme Inhibition | journal | 0.157 Q4 | 19 | 25 | 71 | 1315 | 56 | 64 | 0.85 | 52.60 | |
131 | Research Journal of Pharmacognosy | journal | 0.219 Q4 | 5 | 34 | 66 | 1358 | 66 | 65 | 1.00 | 39.94 | |
130 | Current Opinion in Systems Biology | journal | 1.676 Q1 | 34 | 21 | 140 | 1378 | 455 | 131 | 3.24 | 65.62 | |
129 | Natural Product Sciences | journal | 0.211 Q4 | 31 | 46 | 119 | 1431 | 118 | 119 | 1.04 | 31.11 | |
128 | Assay and Drug Development Technologies | journal | 0.317 Q3 | 65 | 32 | 126 | 1530 | 234 | 118 | 1.61 | 47.81 | |
127 | Nucleic Acid Therapeutics | journal | 1.252 Q1 | 77 | 33 | 125 | 1583 | 502 | 122 | 3.95 | 47.97 | |
126 | Journal of Angiotherapy | journal | 0.106 Q4 | 2 | 40 | 57 | 1623 | 4 | 57 | 0.07 | 40.58 | |
125 | Current Computer-Aided Drug Design | journal | 0.283 Q4 | 32 | 36 | 197 | 1766 | 365 | 191 | 1.76 | 49.06 | |
124 | Journal of Biologically Active Products from Nature | journal | 0.243 Q4 | 18 | 39 | 112 | 1772 | 149 | 111 | 1.14 | 45.44 | |
123 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.326 Q3 | 54 | 51 | 154 | 1785 | 212 | 134 | 0.86 | 35.00 | |
122 | Medicine in Drug Discovery | journal | 0.815 Q2 | 16 | 20 | 68 | 1878 | 328 | 65 | 4.83 | 93.90 | |
121 | DARU, Journal of Pharmaceutical Sciences | journal | 0.625 Q2 | 58 | 43 | 149 | 2213 | 587 | 146 | 2.80 | 51.47 | |
120 | Drug Research | journal | 0.390 Q3 | 71 | 56 | 247 | 2380 | 448 | 240 | 1.77 | 42.50 | |
119 | Current Drug Discovery Technologies | journal | 0.319 Q3 | 49 | 43 | 184 | 2498 | 326 | 180 | 1.82 | 58.09 | |
118 | Drug Development and Registration | journal | 0.187 Q4 | 7 | 125 | 287 | 2528 | 205 | 279 | 0.80 | 20.22 | |
117 | Journal of Antibiotics | journal | 0.546 Q3 | 92 | 85 | 322 | 2598 | 968 | 309 | 2.41 | 30.56 | |
116 | Avicenna Journal of Phytomedicine | journal | 0.409 Q3 | 11 | 56 | 118 | 2644 | 298 | 117 | 2.46 | 47.21 | |
115 | SAR and QSAR in Environmental Research | journal | 0.359 Q3 | 54 | 49 | 147 | 2680 | 414 | 147 | 2.58 | 54.69 | |
114 | Molecular Informatics | journal | 0.550 Q2 | 75 | 54 | 172 | 2684 | 517 | 167 | 2.90 | 49.70 | |
113 | Journal of HerbMed Pharmacology | journal | 0.274 Q4 | 18 | 66 | 171 | 2859 | 246 | 169 | 1.32 | 43.32 | |
112 | Journal of Computer-Aided Molecular Design | journal | 0.609 Q2 | 119 | 49 | 237 | 2930 | 842 | 230 | 3.27 | 59.80 | |
111 | Journal of Natural Medicines | journal | 0.685 Q2 | 59 | 95 | 285 | 2958 | 1010 | 263 | 2.84 | 31.14 | |
110 | ACS Bio and Med Chem Au | journal | 1.036 Q1 | 11 | 48 | 62 | 3007 | 245 | 58 | 3.95 | 62.65 | |
109 | Current Opinion in Pharmacology | journal | 1.203 Q1 | 148 | 45 | 362 | 3026 | 1427 | 335 | 4.06 | 67.24 | |
108 | Cancer Innovation | journal | 0.389 Q3 | 4 | 56 | 20 | 3056 | 23 | 19 | 1.15 | 54.57 | |
107 | Current Gene Therapy | journal | 0.674 Q2 | 80 | 33 | 114 | 3190 | 359 | 106 | 3.41 | 96.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®